Skip to content

Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation

Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02500875
Acronym
PTN-INSTILL
Enrollment
120
Registered
2015-07-17
Start date
2015-01-31
Completion date
2016-01-31
Last updated
2015-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infected Surgical Wound

Keywords

Negative-Pressure Wound Therapy, Topical Negative Pressure Therapy, Sodium Hypochlorite

Brief summary

The objective of this study is to evaluate the effectiveness of PTNi therapy versus PTN therapy without instillation in the treatment of infected surgical wounds. Investigators mean to verify differences of effectiveness between the different types of instilled substances, normal saline versus Amukine Med 0.5%.

Interventions

DEVICEPTNiA
DEVICEPTNiB
DEVICEPTN

Sponsors

Associazione Infermieristica per lo studio delle Lesioni Cutanee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with infected surgical wounds. * Patient age greater than or equal to 18 years. * Patients who have given informed consent to the enrollment in the trial and to the processing of personal data.

Exclusion criteria

* Patients unable of consent. * Patients affected by serious medical conditions that, according to the investigator's opinion, represent a contraindication to the study participation. * Patients affected by wounds with exposition of blood vessels, sutures, organs or nerves and open wounds in mediastinum or abdomen. * Patients with malignancy at the wound. * Patients with untreated osteomyelitis. * Patients with enteric and unexplored fistulas. * Patients with necrotic tissue and eschar. * Immunocompromised patients or in treatment with corticosteroids. * Suspected or known allergic diathesis to the product of medication. * Patients with coagulation disease.

Design outcomes

Primary

MeasureTime frameDescription
Absence of clinical infection (according NHSN 2014)1 monthfrequency of wound without clinical infection
Absence of clinical infection1 monthnumber of days to absence clinical infection

Secondary

MeasureTime frameDescription
Treatment days1 monthnumber of days to wounds treatment
Wound closure1 monthnumber of days to wounds closure
Patient's dischargeparticipants will be followed for the duration of hospital stay, an expected average of 5 weeksnumber of days to patient's discharge
Patient's pain (Numeric Rating Scale (NRS)1 monthassessment with Numeric Rating Scale (NRS)

Countries

Italy

Contacts

Primary ContactPaolo Chiari
paolo.chiari@aosp.it
Backup ContactAngela Peghetti
angela.peghetti@aosp.bo.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026